Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

or GLP-1 receptor agonist after 2013 and who had active COPD as indicated by multiple outpatient or at least one inpatient diagnosis. Patients were divided into drug class groups and matched by a ...

Whenever we give medication to a large portion of the population without long-term safety, one is concerned about what those long-term safety signals are going to be.” “COPD exacerbations ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

The shares of Senores Pharmaceuticals Limited were trading at ₹570.70 up by ₹36.90 or 6.91% on the NSE today at 2.32 pm.

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has ...

The rising prevalence of respiratory diseases and technological advancements drive significant market growth.Pune, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aerosol Drug Delivery Devices Market Size & Growth ...

Approvals last year included rare disease treatments, new oncology drugs, Eli Lilly’s Kisunla, and Mesoblast's Ryoncil.

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...